Terms: = Lymphoma AND HOXD13, SPD, 3239, P35453, HOX4I AND Prognosis
12 results:
1. Correlation between PD-1 and spd-L1 expression levels in peripheral blood of DLBCL patients and their clinicopathological characteristics.
Wang L; Cao C; Qiu J; Zhang J; He Q; Song L; Xie L; Ma J
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):44-50. PubMed ID: 38430041
[TBL] [Abstract] [Full Text] [Related]
2. [Levels and Clinical Significances of spd-1 and spd-L1 in Peripheral Blood of lymphoma Patients].
Liu XL; He P; Lei J; Zou LX; Peng L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1733-1738. PubMed ID: 38071053
[TBL] [Abstract] [Full Text] [Related]
3. Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma.
Feng X; Luo X; Yang Y; Fan Y; Ye Q
Medicine (Baltimore); 2023 Nov; 102(44):e35757. PubMed ID: 37933048
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of soluble programmed cell death ligand-1 (spd-L1) in lymphoma: a systematic review and meta-analysis.
Ding Y; Sun C; Hu L; Xiong S; Zhai Z
Ann Hematol; 2023 Sep; 102(9):2425-2434. PubMed ID: 37382610
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Features, Treatment Strategy, and prognosis of Primary Non-Hodgkin's lymphoma of the Duodenum: A SEER Database Analysis.
Zheng G; Wang Y; Zhao Y; Zheng Z
Can J Gastroenterol Hepatol; 2020; 2020():9327868. PubMed ID: 32399459
[TBL] [Abstract] [Full Text] [Related]
6. Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
Rivas MM; Berro M; Prates MV; Yantorno S; Fiad L; Arbelbide JA; Basquiera AL; Ferini GA; García JJ; García PA; Riera L; Jarchum G; Baso A; Real J; Castro M; Jaimovich G; Martinez Rolón J; Foncuberta C; Saba S; Kusminsky G;
Bone Marrow Transplant; 2020 Jan; 55(1):117-125. PubMed ID: 31435033
[TBL] [Abstract] [Full Text] [Related]
7. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract] [Full Text] [Related]
8. Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis.
Shen H; Ji Y; Zhou D; Zhang Y; Wang W; Sun J; Zhang W
Hematology; 2019 Dec; 24(1):392-398. PubMed ID: 30890046
[TBL] [Abstract] [Full Text] [Related]
9. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
[TBL] [Abstract] [Full Text] [Related]
10. High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.
Wang H; Wang L; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Li ZM; Lu Y
Oncotarget; 2016 May; 7(22):33035-45. PubMed ID: 27105512
[TBL] [Abstract] [Full Text] [Related]
11. High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.
Rossille D; Gressier M; Damotte D; Maucort-Boulch D; Pangault C; Semana G; Le Gouill S; Haioun C; Tarte K; Lamy T; Milpied N; Fest T; ;
Leukemia; 2014 Dec; 28(12):2367-75. PubMed ID: 24732592
[TBL] [Abstract] [Full Text] [Related]
12. Erythrocyte spermine levels: a prognostic parameter in childhood common acute lymphoblastic leukemia.
Bergeron C; Bansard JY; Le Moine P; Bouet F; Goasguen JE; Moulinoux JP; Le Gall E; Catros-Quemener V
Leukemia; 1997 Jan; 11(1):31-6. PubMed ID: 9001415
[TBL] [Abstract] [Full Text] [Related]
